A A A

IHA News

Science Paper published

A recent Science article published by a team of UCL researchers including the IHA's Dr Teresa Niccoli sheds light into toxicity mechanisms. View the article here: http://goo.gl/2sgNCb More...

Published: Aug 19, 2014 10:24:04 AM

Knudra Transgenics prize success for IHA

In a recent competition organised by the biotech company KNUDRA TRANSGENICS three members of the IHA were awarded prizes to make custom transgenic animals.

Second prize $3000 to Nuria Vergara to develop the project "Can human FOXO3a replace DAF-16 to promote longevity in C. elegans?" using CRSPR technology.

Third prize £1500 to Jennifer Tullet to investigate "How do translational errors affect longevity and health in C. elegans?"

Sixth prize $500 to Lamia Mestek to expand our knowledge in "Understanding the role of DAF-16 transcription factor in longevity"

The results of the competition can be checked in the following link: http://knudragrants.knudra.com/?page_id=39

Congratulations to all the winners!!!
More...

Published: Aug 19, 2014 10:10:57 AM

New Wellcome Trust video 'Until' features IHA scientists

The Wellcome Trust’s online publication, Mosaic, have released a new video ‘Until’, an exploration of ageing which asks the question, ‘how long would you like to live?’. The video includes interviews with leading ageing scientists (including the IHA's David Gems and Linda Partridge), transhumanists, elderly people and the young children and asks them when they think would be an appropriate time to die, if they had the choice. It also explores the possibilities and realities of extended lifespans in the future. The video can be found here: http://youtu.be/BsUZHyh4n-c More...

Published: Aug 6, 2014 11:44:15 AM

Lazaros Foukas


Foukas Lab Website


dr lazaros foukas

Contacts
  • Dr
  • Lazaros
  • Foukas
  • Dr Lazaros Foukas
  • Ex: 51612
  • l.foukas@ucl.ac.uk
  • Website
  • https://iris.ucl.ac.uk/iris/extResource/image/01/LFOUK88
  • 2009-04-01
Address
  • 7815
  • London
Joined UCL
  • 2009-04-01

Research Summary

Ageing is a process of gradual decline in the physiological functions of the organism. Amongst other derangements, ageing is associated with dysfunction in carbohydrate and lipid homeostatic regulatory mechanisms. Consequently, middle-aged and old individuals have a higher risk of suffering from metabolic disorders. The rapidly increasing incidence of obesity and type-2 diabetes necessitates the development of novel therapeutic agents to combat these conditions and their numerous debilitating complications.



Cell signalling pathways have been successfully targeted in the therapy of major diseases, such as cancer and inflammation. Signalling pathways that sense nutrient availability and regulate metabolic responses represent potential points of intervention for treatment of metabolic disorders. Key signalling pathways in metabolic regulation are the PI 3-Kinase (PI3K) and Target of Rapamycin (TOR) pathways.



We aim to study the mechanisms by which growth factor and nutrient sensing signalling pathways regulate metabolism and the impact of their perturbation on health in the context of ageing. We use a combination of mammalian genetics, cell based models and pharmacological approaches to identify components of cell signalling pathways which can be targeted in prevention or therapy of age-related diseases.

Research Activities
  • 853
  • Cell signalling
  • 1335
  • age-related disease
  • 1016
  • ageing
  • 1177
  • cancer
  • 1017
  • metabolic regulation
  • 1497
  • obesity
  • 1498
  • type-2 diabetes

Academic Background

  • Award Year
    Qualification
     
    Institution
  • 2003
    PhD
    Doctor of Philosophy
    University College London
  • 1997
    MS
    Master of Science
    University of Patras
  • 1995
    Dip.
    Diploma
    University of Patras

Biography

Lazaros Foukas obtained a PhD in Biochemistry from University College London. He then
went on to conduct postdoctoral research in Bart Vanhaesebroeck’s lab in the
Ludwig Institute for Cancer Research and then in Barts Cancer Institute, Queen
Mary University of London. He joined the Institute of Healthy Ageing at UCL as
a principal investigator in 2009. His research focuses on the role of
signalling pathways in age related pathologies, such as cancer and metabolic disease.

Collaborators
  • LPART24
  • prof dame linda partridge
  • DGEMS65
  • prof david gems
  • ESCHU11
  • dr eugene schuster
  • BFKIN15
  • dr brian king
  • MJKIV95
  • prof mika kivimaki
  • DJPEA06
  • dr daniel pearce
  • MKUMA95
  • prof meena kumari
  • MRDUC42
  • prof michael duchen
  • HPIKH73
  • dr hynek pikhart
  • SJDAW90
  • dr sally dawson
  • RCHAR53
  • dr babis rallis

Page last modified on 28 oct 13 16:14